Terumo Neuro to acquire Arsenal Medical and its NeoCast liquid embolic
Terumo Neuro signed an agreement to acquire clinical-stage biomaterials company Arsenal Medical, adding the investigational NeoCast liquid embolic for chronic subdural hematoma; terms undisclosed.
Read the full coverage, free
We only link to sources you can read without a subscription. How we check.